Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;24(8):e645-e654.
doi: 10.1016/j.clbc.2024.06.007. Epub 2024 Jun 19.

The Challenges of Lobular Carcinomas from a Surgeon's Point of View

Affiliations
Review

The Challenges of Lobular Carcinomas from a Surgeon's Point of View

Margit L H Riis. Clin Breast Cancer. 2024 Dec.

Abstract

Invasive lobular breast cancer (ILC) presents unique challenges and considerations in the realm of surgical management. Characterized by its distinct histological features, including the loss of E-cadherin expression and dys-cohesive growth pattern, ILC often poses diagnostic and therapeutic dilemmas for clinicians. This abstract explores the surgical landscape of ILC, focusing on its epidemiology, clinical presentation, diagnostic modalities, and surgical interventions. Emphasizing the importance of individualized treatment strategies, this narrative delves into the nuances of surgical decision-making, including the role of breast-conserving surgery versus mastectomy, axillary staging, and the significance of margin status. Additionally, advancements in surgical techniques, such as oncoplastic approaches and sentinel lymph node biopsy, are examined in the context of optimizing oncologic outcomes and preserving cosmesis. Through a comprehensive review of current literature and clinical guidelines, this overview aims to provide a nuanced understanding of the surgical considerations inherent to the management of invasive lobular breast cancer.

Keywords: Breast cancer surgery; Challenges in surgical management; Lobular breast cancer; Prognosis; Therapy response.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors have stated that they have no conflicts of interest.